Healthcare Private Equity Platform Arbitrage Modeling
The financial engineering engine: acquiring fragmented solo practices at 6.0x EBITDA, optimizing revenue cycles, and exiting at institutional scale at 13.5x+ EBITDA.
The healthcare consolidation thesis is driven by multiple arbitrage. Individual outpatient practices generating $500K to $2M in standalone EBITDA trade at 5.0x to 7.0x multiples due to doctor concentration and lack of administrative scale. However, institutional healthcare platforms with $15M+ in diversified EBITDA, centralized RCM, autonomous patient acquisition, and bulletproof CPOM compliance command 12.0x to 15.0x+ multiples from mega-funds and strategic payers. Kompanie LLP builds the pro forma financial models that calculate tuck-in accretion, organic EBITDA margin expansion from patient acquisition and billing integrity, and second-bite equity waterfalls for founder-physicians.
Deliverables
- Dynamic 5-year multi-stage tuck-in acquisition waterfall model (.xlsx) with sensitivity analysis.
- Post-acquisition pro forma EBITDA bridge (RCM recovery, ancillary service line additions, overhead consolidation).
- Physician equity rollover modeling under IRC Section 721 with 2nd-bite return projections.
- CIM preparation and data room curation for secondary buyout processes.
Frequently asked questions
What EBITDA scale is required to command a 12x–14x multiple in outpatient healthcare?
In the 2026 market, platform multiples begin expanding significantly once a platform surpasses $10M–$15M in adjusted EBITDA across at least 15–20 clinic locations with demonstrable same-store growth and non-founder-dependent patient flow.
How does multiple arbitrage generate 300%+ ROIC for PE investors?
If a platform buys $1M of standalone EBITDA at 6.0x ($6M cost), expands that EBITDA to $1.35M through forensic RCM (+12%) and patient fill (+23%), and exits at 13.5x ($18.2M exit value), the sponsor generates $12.2M in net capital gain on a single tuck-in—a 3.03x gross MOIC.